At Alkermes, we apply our deep neuroscience expertise to develop medicines designed to help people living with complex and difficult-to-treat psychiatric and neurological disorders. We have a portfolio of proprietary commercial products for the treatment of alcohol dependence, opioid dependence, schizophrenia and bipolar I disorder, and a pipeline of clinical and preclinical candidates in development for neurological disorders. Our patient-inspired science, integrated research strategy, sophisticated development capabilities and specialized commercial infrastructure enable us to pursue the development and commercialization of innovative new medicines, including those for people with conditions that have traditionally been overlooked or stigmatized.
Our greatest strengths at Alkermes are our people and our inherent empathy for patients, families and caregivers. Neurological and psychiatric disorders strike people at the core of who they are and impact many facets of their lives. We work with urgency to develop new treatment options for people living with these conditions.
Beyond our important mission of developing medicines, we believe it is our responsibility to take a holistic approach as we seek to support patients, caregivers and broader impacted communities. We remain committed to patient engagement, responsible and sustainable operations, and equitable access to quality treatment.
Headquartered in Ireland, Alkermes also has a corporate office and research and development center in Massachusetts and a manufacturing facility in Ohio.
See our Community Guidelines: https://www.alkermes.com/social-community-guidelines
Company Details
- Employees
- 2.28K
- Founded
- -
- Address
- Connaught House, 1 Burlington Road,united States
- Phone
- +353 1 772 8000
- bu****@****mes.com
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- alkermes.com
- Keywords
- Pharma, Pharmaceutical, Sales, Marketing, IT, CNS, Addiction, Information technology, Human Resources, Sales, District Sales, Regional Sales, Research & Development, R&D, Manufacturing, Medical Affairs, serious mental illness, biotech, addiction, narcolepsy, neuroscience, sleep disorders, biotech.
- HQ
- Dublin
Alkermes Questions
Alkermes's helpline number is +353 1 772 8000
Alkermes's website is alkermes.com
Alkermes's LinkedIn profile is https://www.linkedin.com/company/alkermes
Alkermes has
2.28K employees.
View email and phone details for 2.28K
employees at Alkermes.
Alkermes's industry is
Biotechnology Research
Alkermes's top competitors are
Biogen,
Apellis Pharmaceuticals,
Vertex Pharmaceuticals,
Alexion Pharmaceuticals, Inc.,
Agios Pharmaceuticals,
Abbvie,
Ardelyx, Inc.,
Akebia Therapeutics,
Alnylam Pharmaceuticals,
Argenx.
Alkermes's support email address is busdev@alkermes.com
Alkermes's categories are Biotechnology Research
Alkermes's founding year is 1987
